Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 31 AL 45

Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC.

Nat Rev Neurol. 2018 Apr;14(4):225-236. doi: 10.1038/nrneurol.2018.9. Epub 2018 Feb 16.

Editorial: Spatial Cognition in Normal Aging, MCI and AD

Ruggiero G, Iachini T.

Curr Alzheimer Res. 2018;15(3):202-204. doi: 10.2174/156720501503180123100912.

Neuroinflammation in Alzheimer's disease: Pleiotropic roles for cytokines and neuronal pentraxins

Swanson A, Wolf T, Sitzmann A, Willette AA.

Behav Brain Res. 2018 Jul 16;347:49-56. doi: 10.1016/j.bbr.2018.02.015. Epub 2018 Feb 17.

Meta-Analysis of Personality Traits in Alzheimer's Disease: A Comparison with Healthy Subjects

D'Iorio A, Garramone F, Piscopo F, Baiano C, Raimo S, Santangelo G.

J Alzheimers Dis. 2018;62(2):773-787. doi: 10.3233/JAD-170901.

Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores

Verwilst P , Kim HS , Kim S , Kang C , Kim JS .

Chem Soc Rev. 2018 Apr 3;47(7):2249-2265. doi: 10.1039/c7cs00706j.

Oral myiasis in older adult with severe Alzheimer's disease

Filho AO, Dias D, Miranda Á, Hebling E.

Spec Care Dentist. 2018 Mar;38(2):99-106. doi: 10.1111/scd.12277. Epub 2018 Mar 5.

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis

Bjerke M, Engelborghs S.

J Alzheimers Dis. 2018;62(3):1199-1209. doi: 10.3233/JAD-170680.

The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades

Molinuevo JL, Minguillon C, Rami L, Gispert JD.

J Alzheimers Dis. 2018;62(3):1067-1077. doi: 10.3233/JAD-170698.

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies

Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, Gupta S, O'Bryant S, Rembach A, Ames D, Ellis K, Fuller SJ, Brown B, Gardener SL, Fernando B, Bharadwaj P, Burnham S, Laws SM, Barron AM, Goozee K, Wahjoepramono EJ, Asih PR, Doecke JD, Salvado O, Bush AI, Rowe CC, Gandy SE, Masters CL.

J Alzheimers Dis. 2018;62(3):965-992. doi: 10.3233/JAD-171145.

Random support vector machine cluster analysis of resting-state fMRI in Alzheimer's disease

Bi XA, Shu Q, Sun Q, Xu Q.

PLoS One. 2018 Mar 23;13(3):e0194479. doi: 10.1371/journal.pone.0194479. eCollection 2018.

Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics

Verheijen J, Sleegers K.

Trends Genet. 2018 Jun;34(6):434-447. doi: 10.1016/j.tig.2018.02.007. Epub 2018 Mar 21.

Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies

Arenaza-Urquijo EM, Vemuri P.

Neurology. 2018 Apr 10;90(15):695-703. doi: 10.1212/WNL.0000000000005303. Epub 2018 Mar 28.

Analysis of Episodes of Care in Medicare Beneficiaries Newly Diagnosed with Alzheimer's Disease

Khandker RK, Black CM, Xie L, Kariburyo MF, Ambegaonkar BM, Baser O, Yuce H, Fillit H.

J Am Geriatr Soc. 2018 May;66(5):864-870. doi: 10.1111/jgs.15281. Epub 2018 Mar 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias